Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation-Reference-Cited by-同舟云学术

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation

Published:2011-03-14 Issue:1 Volume:47 Page:24-32
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Milone G,Poidomani M,Leotta S,Avola G,Camuglia M G,Privitera A,Consoli C,Mercurio S,Romeo M A,Di Marco A,Di Mercurio S,Spadaro A,Palumbo G A,Tedeschi P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201133.pdf

Reference28 articles.

1. Keating S, Suciu S, de Witte T, Zittoun R, Mandelli F, Belhabri A et al. The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia 2003; 17: 60–67.

2. Feller N, Schuurhuis GJ, van der Pol MA, Westra G, Weijers GW, van Stijn A et al. High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome. Leukemia 2003; 17: 68–75.

3. Moog R . Mobilization and harvesting of peripheral blood stem cells. Curr Stem Cell Res Ther 2006; 1: 189–201.

4. Lee J, Lee MH, Park KW, Kang JH, Im DH, Kim K et al. Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission. Int J Hematol 2005; 81: 258–263.

5. Carral A, de la Rubia J, Martỳn G, Mollá S, Martỳnez J, Sanz GF et al. Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies. Leuk Res 2003; 27: 5–12.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study;Leukemia & Lymphoma;2017-06-07

2. Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?;Biology of Blood and Marrow Transplantation;2017-04

3. Wilms' Tumor Gene 1 Transcript Levels in Leukapheresis of Peripheral Blood Hematopoietic Cells Predict Relapse Risk in Patients Autografted for Acute Myeloid Leukemia;Biology of Blood and Marrow Transplantation;2014-10

4. Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation;Biology of Blood and Marrow Transplantation;2013-12

5. In AML patients treated by allogeneic hematopoietic transplantation, CD34+ supermobilization is a negative prognostic factor;Leukemia Research;2013-07